| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 01/20/2011 | CA2766874A1 Tetrazole derivatives |
| 01/18/2011 | CA2500964C Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 01/13/2011 | WO2011005322A2 N-alkoxyamide conjugates as imaging agents |
| 01/13/2011 | WO2011003342A1 Carboxylate compound and use thereof |
| 01/13/2011 | WO2011003191A1 Compositions and methods for enhancing virus efficacy |
| 01/13/2011 | WO2010012442A8 Insecticidal benzenedicarboxamide derivative |
| 01/13/2011 | US20110009409 Dual-acting pyrazole antihypertensive agents |
| 01/13/2011 | US20110009370 Method to enhance tissue regeneration |
| 01/13/2011 | CA2803520A1 N-alkoxyamide conjugates as imaging agents |
| 01/13/2011 | CA2765066A1 Compositions and methods for enhancing virus efficacy |
| 01/12/2011 | CN201701780U Valsartan crystallization-dedicated kettle |
| 01/11/2011 | US7868205 N-[2-amino-5-(2-thienyl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide; antiproliferative, antiprotozoal agent; lymphoma, lung cancer, colon cancer, prostrate cancer, stomach cancer, breast cancer, leukemia |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/06/2011 | CA2766873A1 Therapeutic compositions and related methods of use |
| 01/05/2011 | EP2269977A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 01/05/2011 | CN101935308A New method for synthesizing valsartan |
| 01/04/2011 | US7863475 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/04/2011 | US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 01/04/2011 | CA2319672C Compounds and compositions for delivering active agents |
| 12/29/2010 | WO2010150946A1 Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester |
| 12/29/2010 | WO2010091169A3 Preparation of valsartan |
| 12/29/2010 | EP2265575A2 Sulfonamides |
| 12/29/2010 | CN101463017B Method for synthesizing 5-nitramino tetrazole |
| 12/29/2010 | CA2765566A1 Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester |
| 12/28/2010 | US7858651 Angiotensin II receptor antagonists such as 2-butyl-4-chloro-1-[2'-(1H-tetrazol-5-yl)1,1'-biphenyl-methyl]imidazole-5-carboxylic acid, pivaloyloxymethyl ester, used as hypotensive agents |
| 12/28/2010 | US7858642 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/23/2010 | WO2010147666A1 Compounds useful as carbonic anhydrase modulators and uses thereof |
| 12/23/2010 | WO2010144959A1 Analogues of anti-fibrotic agents |
| 12/23/2010 | WO2010091876A3 Small molecule bradykinin b1 receptor antagonists |
| 12/23/2010 | US20100323410 Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester |
| 12/22/2010 | CN1729158B Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 12/22/2010 | CN101367772B Control method for diovan foreign matter |
| 12/15/2010 | EP2259999A1 Materials for the solid/liquid extraction of heavy metal ions, containing supported n-functionalised polyazacycloalkanes |
| 12/15/2010 | CN101918379A Platinum complex compound and utilization of the same |
| 12/14/2010 | US7851494 administering 5-[(4-(2,6-difluorobenzyloxy)phenyl)-methyl]-1H-tetrazole for the treatment of insulin resistance, diabetes, hyperlipemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 12/09/2010 | US20100311962 Agents For Magnetic Imaging Method |
| 12/09/2010 | US20100311800 Angiotensin ii receptor antagonists |
| 12/09/2010 | US20100311789 3-Substituted Propanamine Compounds |
| 12/09/2010 | US20100311750 Organic compounds |
| 12/08/2010 | EP2257528A2 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
| 12/08/2010 | EP1937257B1 Novel antibiotics comprising bis(1-aryl-5-tetraz0lyl)methane derivatives |
| 12/08/2010 | CN1977837B Application of monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 12/07/2010 | US7847102 generating fuel, is defined as a compound having the structural formula of R3 R1 R2, wherein R1 is a urea group, R2 is a tetrazolyl group with a C N bond to the urea group, and R3 may be defined as a non-tetrazolyl, triazolyl, heterocyclic, heterocyclic amine, aliphatic, aliphatic amine, aryl, alkyl, |
| 12/07/2010 | US7846922 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators |
| 12/02/2010 | WO2010136037A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof |
| 12/02/2010 | US20100305166 Novel compounds |
| 12/02/2010 | US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors |
| 12/02/2010 | US20100305078 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties |
| 12/02/2010 | CA2762137A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof |
| 12/01/2010 | EP1590336B1 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 12/01/2010 | CN101903362A Tetrazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists |
| 12/01/2010 | CN101899003A Quinoline derivative-N-oxide ligand as well as preparation method and application thereof |
| 11/30/2010 | US7842693 For therapy of rheumatoid arthritis, multiple sclerosis, transplant rejection, dermnatitis, eczema, urticaria, vasculitis, inflammatory bowel disease, food allergy and encephalomyelitis |
| 11/25/2010 | WO2010133909A2 Process for preparation of 5-substituted tetrazoles |
| 11/25/2010 | WO2010132992A1 Compounds for the inhibition of herpesviruses |
| 11/24/2010 | CN1897937B 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| 11/24/2010 | CN101890166A Combination of organic compounds |
| 11/23/2010 | US7838683 Synthesis of irbesartan |
| 11/23/2010 | CA2503223C Meso-substituted porphyrins |
| 11/18/2010 | US20100292283 Novel phenyl-acetamide and phenyl-propionamide derivatives useful as potassium channel modulators |
| 11/18/2010 | US20100290992 Nanoparticle nucleic acid binding compound conjugates forming i-motifs |
| 11/17/2010 | EP2250158A2 Angiotensin ii receptor antagonists |
| 11/17/2010 | EP1896491B1 Monoazole ligand platinum analogs |
| 11/17/2010 | EP1786789B1 Process for preparing substituted tetrazoles from aminotetrazole |
| 11/17/2010 | EP1781627B1 A method for preparing irbesartan and intermediates thereof |
| 11/16/2010 | US7834042 Angiotensin II receptor antagonists |
| 11/16/2010 | US7834041 angiotensin II type 1 (AT1) receptor antagonist activity and neprilysin inhibition activity; aryl compounds with both tert-amide and another tert or sec-amide group |
| 11/16/2010 | US7833330 Lead-free primary explosive composition and method of preparation |
| 11/11/2010 | WO2010127440A1 Substituted aromatic compounds and pharmaceutical uses thereof |
| 11/11/2010 | US20100286215 Bis-aromatic compounds useful in the treatment of inflammation |
| 11/11/2010 | US20100286149 Novel benzamide derivatives useful as potassium channel modulators |
| 11/11/2010 | CA2761018A1 Substituted aromatic compounds and pharmaceutical uses thereof |
| 11/03/2010 | EP2246348A1 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives |
| 11/03/2010 | EP2244575A1 Angiotensin ii receptor antagonists |
| 11/03/2010 | CN101160292B Synthesis of cyclen derivatives |
| 11/02/2010 | CA2389681C Npy y5 antagonist |
| 11/02/2010 | CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 10/28/2010 | WO2010123017A1 Tetrazole compound |
| 10/28/2010 | WO2010122968A1 Diacylethylenediamine compound |
| 10/28/2010 | US20100273801 Betulin derived compounds useful as antibacterial agents |
| 10/28/2010 | CA2759264A1 Diacylethylenediamine compound |
| 10/27/2010 | EP2243773A1 Platinum complex compound and utilization of the same |
| 10/20/2010 | EP2240206A1 N-alkoxyamide conjugates as imaging agents |
| 10/20/2010 | EP2240019A1 Acid mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase |
| 10/20/2010 | CN101863849A Method for simultaneously preparing octogen and hexogen |
| 10/19/2010 | US7816538 2-Methylamino-N-{2-(6-{1-methyl-2-(2-methylamino-propionylamino)-3-oxo-3-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-yl]-propoxy}-hexa-2,4-diynyloxy)-1-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-carbonyl]-propyl}-propionamide; mimetics of second mitochondria-derived activator of caspases |
| 10/19/2010 | US7816387 β secretase inhibitor |
| 10/14/2010 | WO2010056205A9 Intravascular contrast agents |
| 10/14/2010 | US20100261772 Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators |
| 10/14/2010 | US20100261760 EP2 Receptor Agonists |
| 10/14/2010 | US20100258220 Gas generant compositions |
| 10/13/2010 | CN101857577A Method for preparing tetrazole compound by taking core-shell magnetic nanoparticles as catalyst |
| 10/13/2010 | CN101362729B Valsartan postprocessing method |
| 10/07/2010 | WO2010114308A1 Heterocycle-amino acid derivatives for targeting cancer tissue and radioactive or non-radioactive labeled compounds thereof |
| 10/07/2010 | US20100256367 Pharmaceutical Composition For Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyactylate Derivatives |
| 10/07/2010 | US20100256315 Non-metallocene catalysts having tetrazol group for olefin polymerization and polymerizing method of olefin using the same |
| 10/07/2010 | US20100256207 Amorphous olmesartan medoxomil |
| 10/07/2010 | US20100256195 Tetrazole-substituted anthranilamides as pesticides |
| 10/07/2010 | US20100256115 Inhibitors of iap |
| 10/06/2010 | EP2234989A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |